Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Eli Lilly and Company for the Transformative Bio-Hermes-002 Study
09 déc. 2024 10h00 HE
|
Global Alzheimer’s Platform Foundation®
Washington D.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Eli Lilly and Company (Lilly) to the Bio-Hermes-002 study. This...
IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights
05 déc. 2024 08h00 HE
|
Biognosys AG
IonOpticks and Biognosys announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns.
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
28 oct. 2024 10h00 HE
|
Global Alzheimer’s Platform Foundation®
Washington D.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These...
Companion Diagnostics Market Size Worth US$ 21.15 billion by 2032, Rising Prevalence of Cancer and Advances in Precision Medicine Drives Growth | Research by SNS Insider
09 oct. 2024 09h00 HE
|
SNS Insider pvt ltd
Pune, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Size Analysis: “According to SNS Insider Research, The Companion Diagnostics Market Size was valued at USD 7.66 Billion in 2023,...
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
04 oct. 2024 10h31 HE
|
Compass Therapeutics
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.
01 oct. 2024 05h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...
Proteomics Market Size To Reach USD 92.8 Billion By 2033, At 14.7% CAGR: Insights by Dimension Market Research
10 sept. 2024 11h09 HE
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Proteomics Market size is expected to reach USD 27.0 billion by 2024 and it is further anticipated to reach a market value of USD...
Precision Medicine Market Is Expected To Reach Revenue Of USD 225.7 Bn By 2033, At 11.6% CAGR: Dimension Market Research
10 sept. 2024 11h03 HE
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Precision Medicine Market is to reach USD 83.9 billion by 2024 and is further anticipated to reach USD 225.7 billion by 2033...
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
29 août 2024 08h27 HE
|
Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Dementia Mission Competition Selects Four Companies For Innovative Alzheimer’s Biomarker Study
10 juil. 2024 09h05 HE
|
Global Alzheimer’s Platform Foundation®
Washington D.C., July 10, 2024 (GLOBE NEWSWIRE) -- With groundbreaking creativity and breathtaking speed, this phase 3 competition, funded by Innovate UK, the UK’s innovation agency, is supporting...